Michael A. Finan

Biography

Prior to his appointment as director in 2015, Michael A. Finan, M.D., served as interim director of MCI (2014-2015), chief of the MCI Division of Gynecologic Oncology (2005-2015) and associate director for Clinical Affairs (2014-2015). He specializes in a variety of gynecologic cancers, including cervical, vaginal, endometrial, vulvar, fallopian tube and ovarian cancer as well as gestational trophoblastic neoplasia. Dr. Finan was the first gynecologist in Mobile to perform robotic surgery with the DaVinci Robotic Surgery System and has been listed among Top Cancer Doctors by Newsweek and Top Doctors by U.S. News and World Report. He is an associate member of the NCI Early Detection Research Network working group and maintains an active collaboration with MCI physicians and scientists in the area of gynecologic cancer research. Dr. Finan is a co-founder of the GO Run in Mobile, a run held each September to raise funds for gynecologic oncology research at MCI. Intellectual property emanating from his research has been licensed to Swift Biotechnology to develop a commercial method for the collection and clinical testing processes related to the early detection of endometrial and ovarian cancers using protein biomarkers. He is a co-inventor on six patents related to ovarian cancer screening technology.

Research Interest

 gynecologic oncology, early detection of endometrial and ovarian cancers using protein biomarkers